Back to company

Biologik ApS: Financial statements 2024

CVR: 36070498

Biologik ApS (CVR 36070498) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 400,167 and a net result of DKK -35,348 compared with DKK 118,661 the year before. That is a decrease of 38.7% compared with the year before. Equity amounted to DKK 235,079. The solvency ratio was 69%. The company had 1 employee in the financial year.

Gross Profit
400,167 kr.
Profit/Loss
-35,348 kr.
Equity
235,079 kr.
Total Assets
340,743 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-400 t.-35 t.235 t.1
2023-653 t.119 t.329 t.1
2022-258 t.-89 t.268 t.1
2021-593 t.215 t.414 t.1
2020-378 t.62 t.199 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Biologik ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Biologik ApS

Biologik ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2014. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Anette Sams Nielsen. The company is owned by Helms & Sams ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 385,601 and a net result of DKK 234,499 compared with DKK -35,348 the year before. Equity amounted to DKK 408,578.